Created in 2012 (United States), HEMODEFEND own 1 sister brand and 2279 competing brands. HEMODEFEND is owned by CYTOSORBENTS CORP USD0.001, listed on the stock exchange of New York HEMODEFEND is part of the Medical Devices & Instruments activity sector.

Share price and profitability of the share CYTOSORBENTS CORP USD0.001 (HEMODEFEND)

Buy CYTOSORBENTS CORP USD0.001 share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 0.81

Portfolio valuation
CYTOSORBENTS CORP USD0.001 (HEMODEFEND) over 5 years* USD 0.09

Stock market history CYTOSORBENTS CORP USD0.001 (HEMODEFEND)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
CYTOSORBENTS CORP USD0.001

See more brands of CYTOSORBENTS CORP USD0.001

Rival brands
HEMODEFEND

Ikonisys
Ikonisys
Nano-X Imaging
Nano-X Imaging
EOFlow
EOFlow
Technology Assessment and Transfer
Technology Assessment and Transfer
Sintx Technologies
Sintx Technologies
Euroapi
Euroapi
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking